These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7858849)

  • 1. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
    Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
    Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.
    Humphries RG; Tomlinson W; Clegg JA; Ingall AH; Kindon ND; Leff P
    Br J Pharmacol; 1995 Jul; 115(6):1110-6. PubMed ID: 7582510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
    Piper AS; Hollingsworth M
    Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
    Bailey SJ; Hourani SM
    Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.
    Hoyle CH; Edwards GA
    Br J Pharmacol; 1992 Oct; 107(2):367-74. PubMed ID: 1422586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands.
    Crack BE; Beukers MW; McKechnie KC; Ijzerman AP; Leff P
    Br J Pharmacol; 1994 Dec; 113(4):1432-8. PubMed ID: 7889301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase.
    Crack BE; Pollard CE; Beukers MW; Roberts SM; Hunt SF; Ingall AH; McKechnie KC; IJzerman AP; Leff P
    Br J Pharmacol; 1995 Jan; 114(2):475-81. PubMed ID: 7533620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder.
    Aronsson P; Andersson M; Ericsson T; Giglio D
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):603-13. PubMed ID: 20406212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
    von Kügelgen I; Späth L; Starke K
    Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
    Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
    Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.
    Bültmann R; Pause B; Wittenburg H; Kurz G; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):481-90. PubMed ID: 8897452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.
    Hoyle CH; Ziganshin AU; Pintor J; Burnstock G
    Br J Pharmacol; 1996 Jul; 118(5):1294-300. PubMed ID: 8818356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
    von Kügelgen I; Stoffel D; Starke K
    Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
    Najbar AT; Li CG; Rand MJ
    Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and pharmacology of selective P2-purinoceptor antagonists.
    Lambrecht G
    J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purinoceptors of the guinea-pig isolated taenia caeci.
    Piper AS; Hollingsworth M
    Eur J Pharmacol; 1995 Jul; 280(2):125-34. PubMed ID: 7589176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
    Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG
    J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
    Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
    Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.